Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in Psoriasis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2190-9172
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in Psoriasis ; volume:10 ; number:6 ; day:13 ; month:10 ; year:2020 ; pages:1383-1396 ; date:12.2020
Dermatology and therapy ; 10, Heft 6 (13.10.2020), 1383-1396, 12.2020
- Urheber
-
Bagel, Jerry
Nelson, Elise
Zapata, James
Hetzel, Alexa
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13555-020-00454-z
- URN
-
urn:nbn:de:101:1-2020122018551884392908
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bagel, Jerry
- Nelson, Elise
- Zapata, James
- Hetzel, Alexa
- SpringerLink (Online service)
Ähnliche Objekte (12)
Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence
Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics
Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics
Evidence-based therapy of Psoriasis: focus on biologics
Autoimmunphänomene in der Therapie der Psoriasis mit Biologics
Biologics als neue Therapieoptionen in der Behandlung der Psoriasis und Psoriasis-Arthritis
Prevalence of antiphospholipid autoantibodies associated with biologics treatment for psoriasis
Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies
Real-World Experience Using Topical Therapy—Calcipotriol and Betamethasone Dipropionate Foam in Adults with Beyond-Mild Psoriasis
Factors Affecting Treatment Persistence in Japanese Patients with Psoriasis Prescribed Biologics: A Real-World Study Using an Insurance Claim Database
Residual metabolic burden in young psoriasis patients successfully treated with biologics
Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review
Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence
Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics
Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics
Evidence-based therapy of Psoriasis: focus on biologics
Autoimmunphänomene in der Therapie der Psoriasis mit Biologics
Biologics als neue Therapieoptionen in der Behandlung der Psoriasis und Psoriasis-Arthritis
Prevalence of antiphospholipid autoantibodies associated with biologics treatment for psoriasis
Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies
Real-World Experience Using Topical Therapy—Calcipotriol and Betamethasone Dipropionate Foam in Adults with Beyond-Mild Psoriasis
Factors Affecting Treatment Persistence in Japanese Patients with Psoriasis Prescribed Biologics: A Real-World Study Using an Insurance Claim Database
Residual metabolic burden in young psoriasis patients successfully treated with biologics
Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review
Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence
Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics
Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics
Evidence-based therapy of Psoriasis: focus on biologics
Autoimmunphänomene in der Therapie der Psoriasis mit Biologics
Biologics als neue Therapieoptionen in der Behandlung der Psoriasis und Psoriasis-Arthritis
Prevalence of antiphospholipid autoantibodies associated with biologics treatment for psoriasis
Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies
Real-World Experience Using Topical Therapy—Calcipotriol and Betamethasone Dipropionate Foam in Adults with Beyond-Mild Psoriasis
Factors Affecting Treatment Persistence in Japanese Patients with Psoriasis Prescribed Biologics: A Real-World Study Using an Insurance Claim Database
Residual metabolic burden in young psoriasis patients successfully treated with biologics